4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001193125-26-126827
Chief Legal Officer sold 10,702 shares at $18.47 ($197,666)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Sullivan Mark · Chief Legal Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-25 | Sale : show line 1 in the form 10b5-1 | −10,702 | $18.47 | $197,666 | 271,079 | D |
| Open-market sales · 10,702 sh · avg $18.47 · $197,666 | ||||||
Loading xslF345X06/ownership.xml…